|
|
Article: Purdue Pharma L.P. Announces Agreement to End OxyContin(R) Patent Lawsuit with Teva Pharmaceuticals.
- Article from:
- PR Newswire
- Article date:
- August 29, 2006
CopyrightCOPYRIGHT 2006 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Teva agrees to stop selling infringing products
STAMFORD, Conn., Aug. 29 /PRNewswire/ -- Purdue Pharma L.P. of Stamford, Connecticut and Teva Pharmaceuticals USA, Inc. of North Wales, Pennsylvania have agreed to end their lawsuit concerning certain Purdue Pharma patents on OxyContin(R) (oxycodone HCl controlled-release) Tablets. Under the terms of the settlement agreement, Teva will cease selling its infringing oxycodone products at a future date and Purdue Pharma will not pursue damages against Teva for past infringement. The settlement agreement is subject to certain contingencies, including review by the United States antitrust agencies and the United States ...